Village Super Market, Inc. Reports Results for the Quarter

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Village Super Market, Inc. Reports Results for the Quarter and Year Ended July 27, 2013

SPRINGFIELD, N.J., Oct. 2, 2013 (GLOBE NEWSWIRE) -- Village Super Market, Inc. (Nasdaq: VLGEA ) today reported its results of operations for the fourth quarter and year ended July 27, 2013.

Net income was $6,203,000 in the fourth quarter of fiscal 2013, a decrease of 31% from the fourth quarter of the prior year. Net income decreased due to lower gross profit percentages and higher operating expenses as a percentage of sales.

Sales were $376,323,000 in the fourth quarter of fiscal 2013, an increase of 1.7% from the fourth quarter of the prior year. Same store sales also increased 1.7%. Sales continued to be impacted by economic weakness, high gas prices and high unemployment, which has resulted in increased sale item penetration and trading down. The Company expects same store sales in fiscal 2014 to increase from 1.5% to 3.5%.

Net income was $25,784,000 in fiscal 2013 compared to $31,445,000 in fiscal 2012. Fiscal 2013 includes income from partnership distributions of $840,000 (net of tax), income from the national credit card lawsuit of $693,000 (net of tax) and a charge for the settlement of a landlord dispute of $376,000 (net of tax), while fiscal 2012 includes a favorable settlement of a pension withdrawal liability of $374,000 (net of tax). Excluding these items from both fiscal years, net income in fiscal 2013 declined 21% compared to the prior year primarily due to lower gross profit percentages and higher operating expenses as a percentage of sales, partially offset by reduced losses in the two Maryland stores compared to the prior year, which was their initial year of operations. Sales in fiscal 2013 were $1,476,457,000, an increase of 3.8% from the prior year. Sales increased due to the acquisition of a store in Old Bridge, New Jersey on January 29, 2012 and a same store sales increase of 2.9%. 

Village Super Market operates a chain of 29 supermarkets under the ShopRite name in New Jersey, Maryland and Eastern Pennsylvania. 

All statements, other than statements of historical fact, included in this Press Release are or may be considered forward-looking statements within the meaning of federal securities law. The Company cautions the reader that there is no assurance that actual results or business conditions will not differ materially from future results, whether expressed, suggested or implied by such forward-looking statements. The Company undertakes no obligation to update forward-looking statements to reflect developments or information obtained after the date hereof. The following are among the principal factors that could cause actual results to differ from the forward-looking statements: local economic conditions; uninsured losses; competitive pressures from the Company's operating environment; the ability of the Company to maintain and improve its sales and margins; the ability to attract and retain qualified associates; the availability of new store locations; the availability of capital; the liquidity of the Company; the success of operating initiatives; consumer spending patterns; the impact of higher energy prices; increased cost of goods sold, including increased costs from the Company's principal supplier, Wakefern; the results of litigation; the results of tax examinations; the results of union contract negotiations; competitive store openings and closings; the rate of return on pension assets; the success of establishing ShopRite's presence in the Maryland market; and other factors detailed herein and in the Company's filings with the SEC. 

VILLAGE SUPER MARKET, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(in Thousands except Per Share Amounts) (Unaudited)
         
  13 Wks Ended 13 Wks Ended 52 Wks Ended 52 Wks Ended
  July 27, 2013 July 28, 2012 July 27, 2013 July 28, 2012
         
Sales  $ 376,323  $ 369,859  $ 1,476,457  $ 1,422,243
         
Cost of sales 274,433 268,660 1,078,696 1,033,416
         
Gross profit 101,890 101,199 397,761 388,827
         
Operating and administrative expense 85,434 80,579 333,230 313,516
         
Depreciation and amortization 5,349 5,146 20,354 19,759
         
Operating income 11,107 15,474 44,177 55,552
         
Income from partnerships -- -- 1,450 --
         
Interest expense  (885)  (1,079)  (3,771)  (4,415)
         
Interest income 715 668 2,783 2,571
         
Income before income taxes 10,937 15,063 44,639 53,708
         
Income taxes 4,734 6,044 18,855 22,263
         
Net income  $ 6,203  $ 9,019  $ 25,784  $ 31,445
         
Net income per share:        
Class A common stock:        
Basic  $ 0.51  $ 0.78  $ 2.18  $ 2.74
Diluted  $ 0.44  $ 0.65  $ 1.85  $ 2.28
         
Class B common stock:        
Basic  $ 0.33  $ 0.51  $ 1.36  $ 1.78
Diluted  $ 0.33  $ 0.51  $ 1.36  $ 1.77
         
Gross profit as a % of sales 27.1% 27.4% 26.9% 27.3%
         
Operating and administrative expense as a % of sales 22.7% 21.8% 22.6% 22.0%

Kevin Begley, CFO (973) 467-2200 - Ext. 220

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 29

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 22

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 16

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 22

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 17

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 22

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Claigan Webinar Tackles Prop 65 Warnings for 2028

Updated Category News Views 26

Buckle up, folks. Here comes a wake-up call for businesses playing loose with their compliance homework on California's Prop 65, thanks to Claigan's latest announcement. They're hosting a webinar on October 7, 2026, gearing up everyone who'll listen for the changes hitting the books in 2028. We’re zooming past the days of generic warnings; pretty soon, it'll be all...

Continue Reading
Understanding Voting Rights and Corporate Governance at Valeo

Updated Category News Views 54

Understanding Voting Rights and Corporate Governance at Valeo Valeo, a prominent name in the mobility technology sector, plays an essential role in implementing innovative solutions that contribute to cleaner, safer, and smarter transportation. As a technology partner to automakers and emerging players in the mobility space, the company's advancements are vital for the...

Continue Reading
Transforming Field Service Management Through Strategic Alliances

Updated Category News Views 101

ServicePower and Marcone Appliance Parts Form Strategic Alliance In a notable development, ServicePower, a recognized leader in field service management software, has announced a strategic partnership with Marcone Appliance Parts, a well-established distributor in North America. This collaboration aims to revolutionize how service providers operate by integrating...

Continue Reading
Goldman Sachs Pushes Gold Price Target to Mid-2026

Updated Category News Views 639

Goldman Sachs Updates Gold Price Forecast Goldman Sachs has recently adjusted its predictions on gold prices, extending the expected timeline for reaching $3,000 per ounce to mid-2026. This update signals a significant shift from earlier forecasts that anticipated this milestone as early as December 2025. Factors Influencing the Price Revision The primary reason for this...

Continue Reading
Comcast's Generous $50,000 Donation for Storm Relief Efforts

Updated Category News Views 213

Comcast's Commitment to Community Support Comcast has recently made a poignant statement of support by donating $50,000 to assist nonprofit organizations as they work to aid those affected by destructive storms. This financially targeted initiative is designed to ensure families and businesses get the vital resources they require during challenging times. Donation Purpose...

Continue Reading